Fig. 6From: Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsiaAngiogenic potential of dasatinib-treated PE-MSC was improved after the treatment. Representative images showing the total network length formed at day 0 and day 8 after senolytic agent treatment of PE-MSC and NP-MSC (a). While no significant difference in angiogenic potential of NP-MSC (n = 9) was observed after the treatment (F = 0.406; df = 8; p = 0.916) (b), NP-MSC co-cultured HUVEC showed significant improvement in angiogenesis (F = 22.436; df = 8; p < 0.001) (c)Back to article page